𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The influence of intercalator binding on DNA triplex stability: correlation with effects on A-tract duplex structure

✍ Scribed by Karin Sandström; Sebastian Wärmländer; Jan Bergman; Robert Engqvist; Mikael Leijon; Astrid Gräslund


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
162 KB
Volume
17
Category
Article
ISSN
0952-3499

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The triplex form of DNA is of interest because of a possible biological role as well as the potential therapeutic use of this structure. In this paper the stabilizing effects of two intercalating drugs, ethidium and the quinoxaline derivative 9‐OH‐B220, on DNA triplexes have been studied by thermal denaturation measurements. The corresponding duplex structures of the DNA triplex systems investigated are either A‐tract or normal B‐DNA. The largest increases in the triplex melting temperatures caused by the intercalators were found for sequences having A‐tract duplex structures. Inserting a single base pair with an N2‐amino group in the minor groove, e.g. a G–C pair, breaks up the A‐tract duplex structure and also reduces the stabilizing effect of the drugs on the triplex melting temperatures. The large drug‐induced increase in triplex melting temperature for complexes having an original duplex A‐tract structure is correlated with a low initial melting point of the triplex, not with the triplex being unusually stable in the presence of the drug. Hence, we conclude that the large thermal stabilizing effect exhibited by ethidium and 9‐OH‐B220 on d__T__~n~·d__A__~n~–d__T__~n~ triplexes is partly caused by the intercalators breaking up the intrinsic A‐tract structure of the underlying duplex. Copyright © 2004 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


The effect of mutations on peptide model
✍ Julie A. Trulson; Glenn L. Millhauser 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 162 KB 👁 3 views

The tumor suppresser protein p53 has been called the "guardian of the genome." DNA damage induces p53 to either halt the cell cycle, allowing for repair, or initiate apoptosis. P53 is mutated in over 50% of human tumors and it has been proposed that many tumorigenic mutations are deleterious to p53